As a practicing medical oncologist, Dr. Reiman’s interest lies in involving patients in research to improve their care. This includes banking of biological specimens and clinical data for research, cancer biomarker studies, pre-clinical and clinical trials of new therapeutic approaches and collaborating with multidisciplinary researchers in areas such as supportive care, and health services and health outcomes. He has active research projects in the study of multiple myeloma, lymphoma and lung cancer.

Dr. Reiman is a principal investigator (PI), co-investigator and/or student supervisor on research funded by Canada’s Foundation for Innovation, the Canadian Institutes of Health Research, MITACS, the Canadian Cancer Society, Lung Cancer Canada, the New Brunswick Health Research Foundation, the Beatrice Hunter Cancer Research Institute, the Dalhousie Medical Research Foundation, and several industry partners. His research team includes postdoctoral fellows, graduate students, medical students and research staff. The Reiman laboratory is located in the Dalhousie Medicine New Brunswick facility on the UNB Saint John campus, and his clinical research takes place at the Saint John Regional Hospital.

Dr. Reiman serves on several regional, national and international research committees and clinical guidelines groups, including the New Brunswick Health Research Foundation, the NCIC Clinical Trials Group, the Canadian Association of Medical Oncologists, the Myeloma Canada Research Network, Lymphoma Canada, the Pan-Canadian Oncology Drug Review and the International Myeloma Working Group.